Inpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans (Buerger's disease)

Mayo Clinic Proceedings

Volumn 73, Issue 6, 1998, Pages 529-532

  Michael Hooten, W ^a   Bruns, Heidi K ^a   Taylor Hays, J ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; ARTERIOGRAPHY; ARTERY OCCLUSION; ARTICLE; BUERGER DISEASE; CASE REPORT; CLAUDICATION; DISEASE COURSE; FOLLOW UP; FOOT ULCER; HOSPITAL PATIENT; HUMAN; MALE; SMOKING; SMOKING CESSATION;

EID: 0031749273     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.6.529     Document Type: Article

References (29)

1. Olin JW. Thromboangiitis obliterans. Curr Opin Rheumatol 1994;6:44-49
2. Mills JL, Porter JM. Buerger's disease (thromboangiitis obliterans). Ann Vase Surg 1991;5:570-572
3. Lie JT. Thromboangiitis obliterans (Buerger's disease) in women. Medicine 1987;65:65-72
4. Hill GL, Smith AH. Buerger's disease in Indonesia: clinical course and prognostic factors. J Chronic Dis 1974;27:205-216
5. Kjeldsen K, Mozes M. Buerger's disease in Israel: investigations on carboxyhemoglobin and serum cholesterol levels after smoking. Acta ChirScand 1969;135:495-498
6. Rao AS, Rao GN, Vasantha VC. Thrombo-angiitis obliterans. J Indian MedAssoc 1976;66:98-101
7. Shionoya S, Hirai M, Kawai S, Seko T, Ban I. Pattern of arterial occlusion in Buerger's disease. Angiology 1982;33:375-384
8. Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn 1989;39:153-158
9. Papa M, Bass A, Adar R, Halperin Z, Schneiderman J, Becker CG, et al. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex. Surgery 1992;111:527-531
10. Adar R, Papa MZ, Halpern Z, Mozes M, Shoshan S, Sofer B, et al. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 1983;308:1113-1116
11. McLoughlin GA, Helsby CR, Evans CC, Chapman DM. Association of HLA-A9 and HLA-B5 with Buerger's disease. BMJ 1976:2:11651166
12. Choudhury NA, Pietraszek MH, Hachiya T, Baba S, Sakaguchi S, Takada Y, et al. Plasminogen activators and plasminogen activator inhibitor I before and after venous occlusion of the upper limb in thromboangiitis obliterans (Buerger's disease). Thromb Res 1992; 66:321-329
13. Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, Hiramori K. Impaired endothelium-dependent vasorelaxation in periph-eral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 1996;94(Suppl 2):II211-II215
14. Lie JT. Thromboangiitis obliterans (Buerger's disease) revisited. Pathol Annu 1988;23:257-291
15. Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger's disease. Eur J Vase Endovasc Surg 1996; 11:335-339
16. Stanson AW. Diagnostic angiography, imaging and intervention. In: Stehbens WE, Lie JT, editors. Vascular Pathology. London: Chapman & Hall Medical; 1995. pp 707-708
17. Grove WJ, Stansby GP. Buerger's disease and cigarette smoking in Bangladesh. Ann R Coll Surg Engl 1992;74:115-117
18. Joyce JW. Buerger's disease (thromboangiitis obliterans). Rheum Dis Clin North Am 1990 May;16:463-470
19. Matsushita M, Shionoya S, Matsumoto T. Urinary cotinine measurement in patients with Buerger's disease-effects of active and passive smoking on the disease process. J Vase Surg 1991;14:53-58
20. Lie JT. Thromboangiitis obliterans (Buerger's disease) in an elderly man after cessation of cigarette smoking-a case report. Angiology 1987:38:864-867
21. Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation 1990;82(Suppl 4):IV3-IV8
22. Case records of the Massachusetts General Hospital (Case 16-1989). N Engl J Med 1989;320:1068-1076
23. O'Dell JR, Linder J, Markin RS, Moore GF. Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum 1987; 30:1054-1056
24. Mills JL, Taylor LM Jr, Porter JM. Buerger's disease in the modern era. Am J Surg 1987;154:123-129
25. Hurt RD, Dale LC, Offord KP, Bruce BK, McClain FL, Eberman KM. Inpatient treatment of severe nicotine dependence. Mayo Clin Proc 1992;67:823-828
26. Hays JT, Eberman KM, Croghan IT, Offord KP, Hurt RD. Residential nicotine dependence treatment for highly nicotine-dependent smokers [abstract]. J Addict Dis 1994;13:244
27. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994:309:842-846
28. Hill HA, Schoenbach VJ, Kleinbaum DG, Strecher VJ, Orleans CT, Gebski VJ, et al. A longitudinal analysis of predictors of quitting smoking among participants in a self-help intervention trial. Addict Behav 1994;19:159-173
29. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T. Cost effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 1997;278:1759-1766